Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Determination of Lanthanum in Lanthanum Dioxycarbonate Drug Substance by Potentiometric Titration

View through CrossRef
This research focused on the determination of lanthanum (LAN) in Lanthanum Dioxycarbonate drug substance through potentiometric titration, a vital aspect in ensuring pharmaceutical drug substance and formulation quality and efficacy. Lanthanum Dioxycarbonate, employed in treating hyperphosphatemia linked to chronic kidney disease, demands precise analytical methods for quality control. The analytical approach involves titrating Lanthanum Dioxycarbonate samples with a known concentration of ethylenediaminetetraacetic acid (EDTA) solution, with the endpoint detected potentiometrically. The study includes a rigorous analytical method validation (AMV) encompassing various parameters. The method demonstrated specificity, confirmed by the absence of blank interference and the yellow color of the solution at the endpoint with the potentiometric curve peaks indicating the absence of lanthanum. Filter compatibility study results showed that the % lanthanum content for centrifuged and filtered samples met the acceptable limits, allowing the use of 0.45 µ PVDF or 0.45 µ nylon syringe filters for regular analysis. Precision was evident from consistent results, with a mean lanthanum content of 99.1% and %RSD of 0.6%. Accuracy was validated through recovery at 10%, 100%, and 150% levels, averaging 96.9% with a %RSD of 4.2%. Linearity was confirmed by a linear relationship between sample weight and titer value, with correlation coefficients exceeding 0.99 for all levels. The robustness of the study results indicated the methods’ resistance under varied conditions. Thus, the validated potentiometric titration method proved effective for determining lanthanum content in Lanthanum Dioxycarbonate drug substance, exhibiting precision, accuracy, linearity, and robustness, supporting its suitability for pharmaceutical quality control. This research addresses critical gaps in analytical methodologies for pharmaceutical drug substances and formulations containing lanthanum, contributing to the understanding of lanthanum determination.
Title: Determination of Lanthanum in Lanthanum Dioxycarbonate Drug Substance by Potentiometric Titration
Description:
This research focused on the determination of lanthanum (LAN) in Lanthanum Dioxycarbonate drug substance through potentiometric titration, a vital aspect in ensuring pharmaceutical drug substance and formulation quality and efficacy.
Lanthanum Dioxycarbonate, employed in treating hyperphosphatemia linked to chronic kidney disease, demands precise analytical methods for quality control.
The analytical approach involves titrating Lanthanum Dioxycarbonate samples with a known concentration of ethylenediaminetetraacetic acid (EDTA) solution, with the endpoint detected potentiometrically.
The study includes a rigorous analytical method validation (AMV) encompassing various parameters.
The method demonstrated specificity, confirmed by the absence of blank interference and the yellow color of the solution at the endpoint with the potentiometric curve peaks indicating the absence of lanthanum.
Filter compatibility study results showed that the % lanthanum content for centrifuged and filtered samples met the acceptable limits, allowing the use of 0.
45 µ PVDF or 0.
45 µ nylon syringe filters for regular analysis.
Precision was evident from consistent results, with a mean lanthanum content of 99.
1% and %RSD of 0.
6%.
Accuracy was validated through recovery at 10%, 100%, and 150% levels, averaging 96.
9% with a %RSD of 4.
2%.
Linearity was confirmed by a linear relationship between sample weight and titer value, with correlation coefficients exceeding 0.
99 for all levels.
The robustness of the study results indicated the methods’ resistance under varied conditions.
Thus, the validated potentiometric titration method proved effective for determining lanthanum content in Lanthanum Dioxycarbonate drug substance, exhibiting precision, accuracy, linearity, and robustness, supporting its suitability for pharmaceutical quality control.
This research addresses critical gaps in analytical methodologies for pharmaceutical drug substances and formulations containing lanthanum, contributing to the understanding of lanthanum determination.

Related Results

Closed-Loop Oxygen Control
Closed-Loop Oxygen Control
<p>Guidelines recommend that oxygen should be titrated to achieve a target oxygen saturation (SpO2 ) range in acutely unwell patients, a concept colloquially known as “swimmi...
The art and science of drug titration
The art and science of drug titration
A “one-size-fits-all” approach has been the standard for drug dosing, in particular for agents with a wide therapeutic index. The scientific principles of drug titration, most comm...
Determination of Acetyl Salicylic Acid in Aspirin tablets
Determination of Acetyl Salicylic Acid in Aspirin tablets
Drug analysis is an important method for determination of active components of any therapeutic drugs. HPLC, Spectrometry, Direct titration and Back-titration are common effective t...
Development of Microcontroller Based Potentiometric Transduction Circuit for a Continuous Fluid Level Sensor
Development of Microcontroller Based Potentiometric Transduction Circuit for a Continuous Fluid Level Sensor
This paper presents the development of microcontroller based potentiometric transduction circuit for a continuous fluid level sensor. The purpose system involved the integration be...
P112 Auto-titrating positive airway pressure in paediatric patients with obstructive sleep apnoea
P112 Auto-titrating positive airway pressure in paediatric patients with obstructive sleep apnoea
Abstract Background Continuous positive airway pressure (CPAP) is the gold standard for treating obstructive sleep apnoea (OSA) ...

Back to Top